Objective This study evaluated the effect of voice intervention in patients who received
chemoradiation to the neck for non-laryngeal head and neck malignancies. Methods Twenty …

We report two patients with Hodgkin's disease on chemotherapy, one with vincristine, the
other with vinblastine, who were referred to the ENT department with a vocal fold palsy …

Inhibition of vascular endothelial growth factor (VEGF) signaling, an initiator of tumor
angiogenesis, inhibits tumor growth and invasion. Bevacizumab, a monoclonal antibody to …

Objectives: To evaluate our experience with a significant number of brain malignancy–
related vocal fold paralysis patients and their response to vocal cord–related therapies …

Background The main cause of voice hoarseness is vocal cord palsy (VCP) that may be
induced by many diseases that could be due to local laryngeal or extra laryngeal causes …

Introduction Gastric cancer (GC) is among the leading neoplasms with highest morbidity and
mortality in the world. Tumor angiogenesis represents one of important targets of …

Introduction Children undergoing cervical and/or thoracic operations are at risk for recurrent
laryngeal nerve injury, resulting in vocal fold movement impairment (VFMI). Screening for …

Background Laryngeal dysfunction in the oncology population is common and may detract
from quality of life (QoL) due to vocal restriction and aspiration. Therapies to address this …

OBJECTIVE: To compare practices of the American Broncho-Esophagological Association
(ABEA) membership regarding the evaluation and management of unilateral vocal fold …

Background: Concurrent chemoradiotherapy (CCRT) used for definitive management of
locally advanced head and neck squamous cell carcinoma (HNSCC) allows organ …